Difference between revisions of "Cerwenka A, et al, J Exp Med (1999), cited as Ref 36 in DOI:10.1007/s11886-020-01292-3 (Q10545)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Third Author string (P151): Harmsen AG, #quickstatements; #temporary_batch_1592503188634)
(‎Created claim: Fourth Author string (P152): Dutton RW, #quickstatements; #temporary_batch_1592503336917)
Property / Fourth Author string
 +
Dutton RW
Property / Fourth Author string: Dutton RW / rank
 +
Normal rank

Revision as of 18:03, 18 June 2020

Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
Language Label Description Also known as
English
Cerwenka A, et al, J Exp Med (1999), cited as Ref 36 in DOI:10.1007/s11886-020-01292-3
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.

    Statements

    Q10356 (Deleted Item)
    0 references
    Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection (English)
    0 references
    Cerwenka A
    0 references
    Morgan TM
    0 references
    Harmsen AG
    0 references
    Dutton RW
    0 references